Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
BorgWarner Inc. ( BWA - Analyst Report ) announced the opening of a new facility in Manesar, near New Delhi, India. The 86,000-square-foot facility will primarily manufacture exhaust gas recirculation (EGR) coolers, tubes, valves and modules.
The Manesar plant will replace the former facility in Faridabad and will expand the production capacity of the company. It will also support domestic and international automakers by providing sales, design, and test validation capabilities. The customers includes Maruti Suzuki, Mahindra & Mahindra, Renault, General Motors Company ( GM - Analyst Report ) , Tata Motors Limited ( TTM - Snapshot Report ) , Fiat S.p.A. ( FIATY ) , Ashok Leyland, Volvo Eicher and others.
The EGR technologies help the auto companies to reduce nitrogen oxide (NOx) emission and meet strict emission regulations. The EGR systems are designed in such a manner that it can be used in any application from passenger cars to commercial trucks.
Management believes that the new facility will strengthen the market position of the company in EGR coolers business and will also support the rising demand for EGR products. With this, the company expects that Indian EGR business will improve by 35% over the next five years.
Moreover, the new BorgWarner facility in India is an eco-friendly facility. It makes maximum utilization of natural light and features LED lighting, which preserve energy and collects rainwater for landscaping and sanitation.
BorgWarner is a leading manufacturer of powertrain products for the world's major automakers. The company operates in 57 locations in 19 countries, providing products that are capable of improving vehicle performance and stability along with fuel efficiency and emission levels. It retains a Zacks Rank #3 (Hold).
BorgWarner posted a 3.5% increase in profits to $1.19 per share (excluding non-recurring items) in the third quarter of the year from $1.15 in the same quarter of 2011. The profit was in line with the Zacks Consensus Estimate.
Revenues dipped 5% to $1.7 billion due to a 6% fall in light vehicle production in Europe, which comprises over half of the company’s ales. However, excluding the impact of foreign currencies and dispositions in 2011, net sales went up 2% in the quarter.
Read the full Analyst Report on BWA
Read the full on FIATY
Read the full Analyst Report on GM
Read the full Snapshot Report on TTM